203 related articles for article (PubMed ID: 26197747)
1. [A Case of Pneumatosis Cystoides Intestinalis Secondary to Gefitinib Therapy for Lung Adenocarcinoma].
Ando T; Sakata J; Maruyama T; Hirose Y; Okabe Y; Takizawa K; Nagahashi M; Shimada Y; Ishikawa T; Kameyama H; Kobayashi T; Minagawa M; Kosugi S; Koyama Y; Ohtsubo A; Watanabe S; Wakai T
Gan To Kagaku Ryoho; 2015 Jul; 42(7):847-9. PubMed ID: 26197747
[TBL] [Abstract][Full Text] [Related]
2. Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report.
Maeda A; Nakata M; Shimizu K; Yukawa T; Saisho S; Okita R
World J Surg Oncol; 2016 Jun; 14(1):175. PubMed ID: 27495256
[TBL] [Abstract][Full Text] [Related]
3. Pneumatosis cystoides intestinalis after gefitinib therapy for pulmonary adenocarcinoma.
Iwasaku M; Yoshioka H; Korogi Y; Kunimasa K; Nishiyama A; Nagai H; Ishida T
J Thorac Oncol; 2012 Jan; 7(1):257. PubMed ID: 22173663
[No Abstract] [Full Text] [Related]
4. Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma.
Lee JY; Han HS; Lim SN; Shim YK; Choi YH; Lee OJ; Lee KH; Kim ST
BMC Cancer; 2012 Mar; 12():87. PubMed ID: 22405425
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis.
Uruga H; Moriguchi S; Takahashi Y; Ogawa K; Murase K; Mochizuki S; Hanada S; Takaya H; Miyamoto A; Morokawa N; Kishi K
BMC Cancer; 2018 Aug; 18(1):825. PubMed ID: 30115025
[TBL] [Abstract][Full Text] [Related]
6. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the lung with rare insertion mutation in EGFR exon 19 that had partial response to gefitinib: a case report.
Kozlov V; Karpov I; Kovalenko S; Shamanin V
Exp Oncol; 2017 Jul; 39(2):155-156. PubMed ID: 29483495
[TBL] [Abstract][Full Text] [Related]
8. Pneumatosis cystoides intestinalis presenting as pneumoperitoneum in a patient with chronic obstructive pulmonary disease: a case report.
Iida A; Naito H; Tsukahara K; Yumoto T; Nosaka N; Kawana S; Sato K; Takeuchi N; Soneda J; Nakao A
J Med Case Rep; 2017 Feb; 11(1):55. PubMed ID: 28241852
[TBL] [Abstract][Full Text] [Related]
9. [Case of portal venous gas and pneumatosis cystoides intestinalis occurring during chemotherapy for a castration-resistant prostate cancer].
Iwasaki M; Okajima K; Takano T; Misaki H
Hinyokika Kiyo; 2014 Nov; 60(11):575-8. PubMed ID: 25511946
[TBL] [Abstract][Full Text] [Related]
10. Pneumatosis cystoides intestinalis associated with sunitinib and a literature review.
Lee YS; Han JJ; Kim SY; Maeng CH
BMC Cancer; 2017 Nov; 17(1):732. PubMed ID: 29121860
[TBL] [Abstract][Full Text] [Related]
11. Massive pneumatosis intestinalis: CT diagnosis.
Ryback LD; Shapiro RS; Carano K; Halton KP
Comput Med Imaging Graph; 1999; 23(3):165-8. PubMed ID: 10397360
[TBL] [Abstract][Full Text] [Related]
12. The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy.
Yang CJ; Hung JY; Tsai MJ; Wu KL; Liu TC; Chou SH; Lee JY; Hsu JS; Huang MS; Chong IW
BMC Pharmacol Toxicol; 2017 May; 18(1):21. PubMed ID: 28486985
[TBL] [Abstract][Full Text] [Related]
13. Minimal change nephrotic syndrome associated with gefitinib and a successful switch to erlotinib.
Maruyama K; Chinda J; Kuroshima T; Kabara M; Nakagawa N; Fujino T; Yamamoto Y; Ohsaki Y; Ogawa Y; Hasebe N
Intern Med; 2015; 54(7):823-6. PubMed ID: 25832950
[TBL] [Abstract][Full Text] [Related]
14. [A case of pneumatosis cystoides intestinalis secondary to sunitinib treatment for renal cell carcinoma].
Ohtake S; Namura K; Fujikawa A; Sawada T; Ohta J; Moriyama M; Hayashi H
Hinyokika Kiyo; 2014 Feb; 60(2):75-8. PubMed ID: 24755817
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.
Takeda M; Okamoto I; Tsurutani J; Oiso N; Kawada A; Nakagawa K
Jpn J Clin Oncol; 2012 Jun; 42(6):528-33. PubMed ID: 22457323
[TBL] [Abstract][Full Text] [Related]
16. Pneumatosis cystoides intestinalis mimicking acute abdomen.
Kaya B; Celik K; Karip AB; Altun H; Ozbay Özel N; Bat O; Memişoğlu K
Turk J Gastroenterol; 2014 Aug; 25(4):426-8. PubMed ID: 25254527
[TBL] [Abstract][Full Text] [Related]
17. [A case of pneumatosis cystoides intestinalis: diagnosed by CT colonoscopy].
Ham JH; Kim TH; Han SW; Cho KJ; Choi SO; Pack JS; Yang SE; Kim SH; Yang SA; Lee YJ; Kim ES; Kim CW
Korean J Gastroenterol; 2007 Nov; 50(5):334-9. PubMed ID: 18159167
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte Telomere Length and Clinical Outcomes of Advanced Lung Adenocarcinoma Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment.
Li J; Zhang L; Zhu H; Pan W; Zhang N; Li Y; Yang M
DNA Cell Biol; 2018 Nov; 37(11):903-908. PubMed ID: 30277797
[TBL] [Abstract][Full Text] [Related]
19. Pneumatosis cystoides intestinalis after fluorouracil chemotherapy for rectal cancer.
Mimatsu K; Oida T; Kawasaki A; Kano H; Kuboi Y; Aramaki O; Amano S
World J Gastroenterol; 2008 May; 14(20):3273-5. PubMed ID: 18506940
[TBL] [Abstract][Full Text] [Related]
20. Good response to gefitinib for lung adenocarcinoma with hyperamylasemia: a case report.
Ko HW; Tsai YH; Yu CT; Huang CY; Chen CH
Chang Gung Med J; 2008; 31(6):606-11. PubMed ID: 19241901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
